Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril arginine + amlodipine versus valsartan-based antihypertensive strategy in mild to moderate hypertension
NL-OMON34436Phase 3Not yet recruiting
- Sponsor
- Servier
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of perindopril, amlodipine and valsartan in hypertension (HTN) (2 arms), sponsored by Servier. Planned start Nov 2010; status: not yet recruiting.
02
Drugs
perindoprilamlodipinevalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON34436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34436.